vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -1.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
PBYI vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $78.6M |
| Net Profit | — | $-140.1M |
| Gross Margin | 69.3% | 74.2% |
| Operating Margin | 22.7% | -182.2% |
| Net Margin | — | -178.3% |
| Revenue YoY | 27.7% | 0.4% |
| Net Profit YoY | — | -3304.1% |
| EPS (diluted) | $0.26 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $78.6M | ||
| Q3 25 | $54.5M | $77.7M | ||
| Q2 25 | $52.4M | $75.6M | ||
| Q1 25 | $46.0M | $77.3M | ||
| Q4 24 | $59.1M | $78.3M | ||
| Q3 24 | $80.5M | $79.1M | ||
| Q2 24 | $47.1M | $74.9M | ||
| Q1 24 | $43.8M | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $8.8M | $-6.4M | ||
| Q2 25 | $5.9M | $-102.3M | ||
| Q1 25 | $3.0M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $20.3M | $3.2M | ||
| Q2 24 | $-4.5M | $-4.1M | ||
| Q1 24 | $-4.8M | $-5.2M |
| Q4 25 | 69.3% | 74.2% | ||
| Q3 25 | 77.7% | 74.4% | ||
| Q2 25 | 76.5% | 75.7% | ||
| Q1 25 | 77.1% | 75.9% | ||
| Q4 24 | 76.4% | 76.3% | ||
| Q3 24 | 63.9% | 77.8% | ||
| Q2 24 | 77.4% | 78.2% | ||
| Q1 24 | 75.5% | 76.2% |
| Q4 25 | 22.7% | -182.2% | ||
| Q3 25 | 17.6% | -3.9% | ||
| Q2 25 | 12.7% | -138.7% | ||
| Q1 25 | 8.7% | -4.7% | ||
| Q4 24 | 22.6% | -1.5% | ||
| Q3 24 | 27.4% | -0.9% | ||
| Q2 24 | -4.6% | -4.6% | ||
| Q1 24 | -5.3% | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | 16.2% | -8.3% | ||
| Q2 25 | 11.2% | -135.2% | ||
| Q1 25 | 6.5% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 25.2% | 4.1% | ||
| Q2 24 | -9.6% | -5.4% | ||
| Q1 24 | -11.0% | -6.5% |
| Q4 25 | $0.26 | $-1.68 | ||
| Q3 25 | $0.17 | $-0.08 | ||
| Q2 25 | $0.12 | $-1.15 | ||
| Q1 25 | $0.06 | $-0.09 | ||
| Q4 24 | $0.40 | $-0.04 | ||
| Q3 24 | $0.41 | $0.03 | ||
| Q2 24 | $-0.09 | $-0.04 | ||
| Q1 24 | $-0.10 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $115.7M |
| Total DebtLower is stronger | $22.7M | $280.1M |
| Stockholders' EquityBook value | $130.3M | $484.4M |
| Total Assets | $216.3M | $1.2B |
| Debt / EquityLower = less leverage | 0.17× | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $115.7M | ||
| Q3 25 | $94.4M | $95.7M | ||
| Q2 25 | $96.0M | $162.6M | ||
| Q1 25 | $93.2M | $165.5M | ||
| Q4 24 | $101.0M | $189.5M | ||
| Q3 24 | $96.7M | $168.7M | ||
| Q2 24 | $96.8M | $147.1M | ||
| Q1 24 | $107.2M | $128.3M |
| Q4 25 | $22.7M | $280.1M | ||
| Q3 25 | $34.0M | $279.5M | ||
| Q2 25 | $45.3M | $279.0M | ||
| Q1 25 | $56.7M | $497.6M | ||
| Q4 24 | $68.0M | $496.8M | ||
| Q3 24 | $79.3M | $496.2M | ||
| Q2 24 | $90.7M | $435.6M | ||
| Q1 24 | $102.0M | $434.9M |
| Q4 25 | $130.3M | $484.4M | ||
| Q3 25 | $115.3M | $616.9M | ||
| Q2 25 | $104.7M | $633.7M | ||
| Q1 25 | $97.1M | $755.7M | ||
| Q4 24 | $92.1M | $761.3M | ||
| Q3 24 | $71.1M | $754.7M | ||
| Q2 24 | $48.5M | $815.4M | ||
| Q1 24 | $51.0M | $813.8M |
| Q4 25 | $216.3M | $1.2B | ||
| Q3 25 | $202.9M | $1.3B | ||
| Q2 25 | $194.9M | $1.4B | ||
| Q1 25 | $196.2M | $1.5B | ||
| Q4 24 | $213.3M | $1.6B | ||
| Q3 24 | $220.7M | $1.6B | ||
| Q2 24 | $205.0M | $1.5B | ||
| Q1 24 | $214.1M | $1.5B |
| Q4 25 | 0.17× | 0.58× | ||
| Q3 25 | 0.30× | 0.45× | ||
| Q2 25 | 0.43× | 0.44× | ||
| Q1 25 | 0.58× | 0.66× | ||
| Q4 24 | 0.74× | 0.65× | ||
| Q3 24 | 1.12× | 0.66× | ||
| Q2 24 | 1.87× | 0.53× | ||
| Q1 24 | 2.00× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $23.3M |
| Free Cash FlowOCF − Capex | $14.4M | $23.2M |
| FCF MarginFCF / Revenue | 19.1% | 29.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $23.3M | ||
| Q3 25 | $9.7M | $32.2M | ||
| Q2 25 | $14.1M | $33.1M | ||
| Q1 25 | $3.6M | $2.5M | ||
| Q4 24 | $15.6M | $34.3M | ||
| Q3 24 | $11.0M | $60.1M | ||
| Q2 24 | $1.0M | $31.0M | ||
| Q1 24 | $11.2M | $24.8M |
| Q4 25 | $14.4M | $23.2M | ||
| Q3 25 | $9.7M | $32.1M | ||
| Q2 25 | $14.1M | $33.0M | ||
| Q1 25 | $3.6M | $2.4M | ||
| Q4 24 | $15.6M | $34.0M | ||
| Q3 24 | $11.0M | $59.8M | ||
| Q2 24 | $1.0M | $30.5M | ||
| Q1 24 | — | $24.7M |
| Q4 25 | 19.1% | 29.6% | ||
| Q3 25 | 17.7% | 41.3% | ||
| Q2 25 | 26.8% | 43.6% | ||
| Q1 25 | 7.7% | 3.0% | ||
| Q4 24 | 26.4% | 43.5% | ||
| Q3 24 | 13.7% | 75.6% | ||
| Q2 24 | 2.1% | 40.7% | ||
| Q1 24 | — | 30.6% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.6% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
